ARCHIVES

In Brief: Senate approves $13.69 Billion for NIH, House To Act This Week; Amounts Are Close

This article is from The Cancer Letter archive.

Vol. 23 No. 36 | September 19, 1997

Download PDF Visit The Full Archive

Related Articles

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

In Brief: Cancer Act Extension, Training Bill Breezing Through Congress; Army Causes Ft. Detrick Flap

July 5, 1974

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005

Ethics Commission Say HHS Should Test Injury Compensation

June 18, 1982

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998